<code id='002D0DF2C3'></code><style id='002D0DF2C3'></style>
    • <acronym id='002D0DF2C3'></acronym>
      <center id='002D0DF2C3'><center id='002D0DF2C3'><tfoot id='002D0DF2C3'></tfoot></center><abbr id='002D0DF2C3'><dir id='002D0DF2C3'><tfoot id='002D0DF2C3'></tfoot><noframes id='002D0DF2C3'>

    • <optgroup id='002D0DF2C3'><strike id='002D0DF2C3'><sup id='002D0DF2C3'></sup></strike><code id='002D0DF2C3'></code></optgroup>
        1. <b id='002D0DF2C3'><label id='002D0DF2C3'><select id='002D0DF2C3'><dt id='002D0DF2C3'><span id='002D0DF2C3'></span></dt></select></label></b><u id='002D0DF2C3'></u>
          <i id='002D0DF2C3'><strike id='002D0DF2C3'><tt id='002D0DF2C3'><pre id='002D0DF2C3'></pre></tt></strike></i>

          entertainment

          entertainment

          author:knowledge    Page View:5112
          Lee Klafczynski for STAT

          WASHINGTON — Congress is considering a must-pass pandemic preparedness bill that presents a good opportunity to fix the nation’s current drug shortages problem, which both parties want to do. But most indications are that lawmakers will let that opportunity pass them by.

          Although not new, drug shortages are now a crisis, with an increasing number of reports about cancer doctors having to ration chemotherapies and other drugs.

          advertisement

          Politicians have been well aware of the problem for years. At the request of a large bipartisan group of lawmakers, a task force chaired by the Food and Drug Administration in 2019 reported on the root causes of drug shortages.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          After affirmative action ruling, medical educators look to 'holistic review'
          After affirmative action ruling, medical educators look to 'holistic review'

          AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

          read more
          Why Novartis is going to walk from its acquisition of MorphoSys
          Why Novartis is going to walk from its acquisition of MorphoSys

          MollyFerguson/STATNovartissaidMondaythatitintendstobuyMorphoSysforjustunder$3billion.Thedealwillnotc

          read more
          Apple is now the first public company to be valued at $3 trillion
          Apple is now the first public company to be valued at $3 trillion

          6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

          read more

          A single Democrat is willing to weaken Medicare negotiation power

          U.S.RepresentativeDonDavis(D-N.C.)WikimediaCommonsWASHINGTON—TwoRepublicanlawmakerswhointroducedlegi